Medical Hypotheses
Volume 63, Issue 4 , Pages 684-687, 2004

DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients

  • Ozden Altundag

      Affiliations

    • Department of Medical Oncology, Institute of Oncology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100 Ankara, Turkey
    • ,
  • Kadri Altundag

      Affiliations

    • Department of Medical Oncology, Institute of Oncology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100 Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Present address: 8181 Fannin Street No. 728, Houston, TX 77054, USA. Tel.: +1-713-795-0438/+90-312-3052954; fax: +1-713-794-4385/+90-312-3242009
    • ,
  • Mehmet Gunduz

      Affiliations

    • Department of Oral Pathology and Medicine, Graduate School of Medicine and Dentistry, Okayama University, Shikata, Japan

Received 15 March 2004; accepted 17 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(04)00228-2

doi:10.1016/j.mehy.2004.03.017

Medical Hypotheses
Volume 63, Issue 4 , Pages 684-687, 2004

Article Tools